Skip to content
MRD Watch

Wednesday, November 18, 2026

Subscribe
Sponsor this briefing. One site and newsletter slot, $250/week.

Briefing

Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma

NEJM 2004 quantification study showing that plasma EBV DNA is a prognostic marker in advanced nasopharyngeal carcinoma.

N Engl J MedPubMed 15190138DOI 10.1056/NEJMoa032260